A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyman, J., Chen, H., Di Fiore, P. P., De Camilli, P., & Brunger, A. T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.537 · Cited by 158
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
“It has also been shown that the interaction between p130Cas, Pyk2, and PI3K activates ribo- somal p70s6 kinase, implicated in ANG II-mediated protein synthesis.”
BackgroundInfluentialAngiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Counter-regulatory renin–angiotensin system in cardiovascular disease
Paz Ocaranza, M., Riquelme, J. A., García, L., Jalil, J. E., Chiong, M., Santos, R. A. S., & Lavandero, S. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0244-8 · Cited by 561
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Schefe, J. H., Menk, M., Reinemund, J., Effertz, K., Hobbs, R. M., Pandolfi, P. P., Ruiz, P., Unger, T., & Funke-Kaiser, H. (2006) · Circulation Research · doi:10.1161/01.res.0000251700.00994.0d · Cited by 302
AT2 receptors: Functional relevance in cardiovascular disease
Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.009 · Cited by 237
“Interestingly, PLZF has also been found to associate with AT2R in the heart (Senbonmatsu et al., 2003), and such an interaction has been suggested as explanation for the AT2R-mediated cardiac growth-promoting effects deduced from several AT2R knockout studies (Senbonmatsu et al., 2000; Ichihara et…”
BackgroundInfluentialFeldt, S., Batenburg, W. W., Mazak, I., Maschke, U., Wellner, M., Kvakan, H., Dechend, R., Fiebeler, A., Burckle, C., Contrepas, A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101444 · Cited by 236
“[ 31 ] Whether prorenin/renin signaling provides for cross-talk to Ang II-AT2 receptor signaling needs to be further defined.”
BackgroundThe Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
(Pro)renin and its receptors: pathophysiological implications
Batenburg, W. W., & Danser, A. H. J. (2012) · Clinical Science · doi:10.1042/cs20120042 · Cited by 58
Liška, F., Landa, V., Zídek, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Strnad, H., Trnovská, J., Škop, V., Kazdová, L., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08798 · Cited by 42
Mineralocorticoid receptor promotes cardiac macrophage inflammaging
Fraccarollo, D., Geffers, R., Galuppo, P., & Bauersachs, J. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01032-6 · Cited by 32
Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115370 · Cited by 19
Metadata
- Authors
- Senbonmatsu, T.
- Venue
- The EMBO Journal
- Published
- 2003-12-15
- Volume
- 22
- Issue
- 24
- Pages
- 6471-6482
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2018263437
- Cited by
- 192
- References
- 1
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.